Funding helps put UC near the forefront of cancer research
November 4, 2020
Benjamin Harrison The ongoing fight against cancer isn’t going to go away anytime soon, but the work from In-Kwon Kim, assistant professor of chemistry, and his team could drastically improve the field of cancer research. Kim recently received a 4-year grant ($792,000) from the American Cancer Society. With the help of this grant, Kim and his team will put the University of Cincinnati at the head of the next-stage cancer treatment. Before coming to UC, Kim was an assistant professor of biochemistry and molecular biophysics at Washington University’s School of Medicine. He decided to take the opportunity in precision cancer medicine in UC and join the chemistry department in 2016. Kim’s research group focuses primarily on the ADP-ribosylation cycle that regulates many cellular signaling pathways, including DNA repair and cell death. Currently, Kim and his team are working with human enzymes that remove different types of ADP-ribosylations. These enzymes play key roles in DNA repair and are often associated with breast cancer.